Dr Lal PathLabs made audio recording of Q4 & FY26 earnings conference call available on company website.
Disclosure made pursuant to SEBI Listing Regulations 30 and 46(2) requirements for investor communication.
Conference call was held on April 30, 2026 with investors and analysts to discuss quarterly results.